Molecular Imaging: Page 83

European debate arises over best PET/CT parameters for NSCLC

By Wayne Forrest

An interesting dialogue has developed on the worth of maximum standardized uptake values from FDG-PET/CT scans to accurately diagnose mediastinal disease in non-small cell lung cancer (NSCLC) patients. In an editorial in European Journal of Radiology, Italian researchers question conclusions from a recently published Irish study.

May 28, 2014

U.K. updates guidance on pediatric PET/CT

By Philip Ward

The U.K. Royal College of Radiologists (RCR) has published updated recommendations for the use of pediatric PET/CT. The 16-page document can be downloaded free of charge from the RCR's website.

May 15, 2014

Safety in radiotherapy: Help or hindrance?

By Tami Freeman, PhD

Is the strong focus on radiation protection and safety hampering the introduction of new radiotherapy technologies and treatment strategies? That was the question under discussion during a lively debate at the recent European Society for Radiotherapy & Oncology meeting in Vienna, Austria.

May 14, 2014

AIPES: Translational research must bridge Valley of Death

By Leo Cendrowicz

BRUSSELS - A senior German molecular imaging specialist is encouraging clinical and basic scientists to communicate better, claiming there is excellent basic research but a lack of translation, and translational research must "cross the Valley of Death."

May 13, 2014

AIPES: Molecular imaging urgently needs evangelists

By Leo Cendrowicz

BRUSSELS - Molecular imaging and nuclear medicine are still widely seen as obscure and unproven specialties, and need established figures to champion them, a leading European nuclear medicine expert told delegates at an Association of Imaging Producers & Equipment Suppliers (AIPES) event.

May 12, 2014

Start-up firm Blue Earth Diagnostics develops prostate PET agent

By Wayne Forrest

Researchers from GE Healthcare have set out on their own with Blue Earth Diagnostics, a start-up with plans to commercialize a PET radiopharmaceutical they hope will prove more useful than FDG for detecting and assessing recurrent prostate cancer.

May 4, 2014

AuntMinnieEurope.com Molecular Imaging Insider

By Wayne Forrest

April 21, 2014

MR attenuation correction for PET/MRI must consider bone factor

By Wayne Forrest

When it comes to standard MR attenuation correction for whole-body PET/MRI oncology scans, Danish researchers are advising users to account for bone attenuation to eliminate bias in tracer uptake of bony and soft-tissue lesions.

April 21, 2014

IBA to place 3 cyclotrons in China

By AuntMinnieEurope.com staff writers

Ion Beam Applications (IBA) has signed contracts with radiopharmaceutical provider HTA to deliver and install three Cyclone 18 cyclotrons in China.

April 17, 2014

PET shows vegetative patients' chance for recovery

By Wayne Forrest

Belgian researchers have found that FDG-PET scans are more useful than functional MRI in identifying which severely brain damaged individuals in vegetative states have the potential to recover consciousness.

April 15, 2014

ABT Molecular places cyclotron in Russia

By AuntMinnieEurope.com staff writers

ABT Molecular Imaging has implemented its first cyclotron in Russia for the production of PET radiopharmaceuticals.

April 14, 2014

Profile of medical physicists looks set to rise sharply

The new European Union directive on the safety of ionizing radiation in medicine requires closer involvement of medical physics experts in radiology. This interview with Dr. Horst Lenzen discusses how this requirement can be met without placing excessive demands upon hospitals.

April 14, 2014

Previous Page

Page 83 of 122

Next Page